Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells.
Wu Y, He Z, Li S, Tang H, Wang L, Yang S, Dong B, Qin J, Sun Y, Yu H, Zhang Y, Zhang Y, Guo Y, Wang Q.
Wu Y, et al. Among authors: yu h.
Curr Cancer Drug Targets. 2019;19(10):796-806. doi: 10.2174/1568009619666190103122735.
Curr Cancer Drug Targets. 2019.
PMID: 30605061